All articles
Industry TrendsNovember 2, 2026·3 min read

What Sponsors Are Really Evaluating When They Pick Sites

Site selection decisions are risk decisions, not capability decisions. Here is what sponsors and CROs actually check — and the records you should be keeping before the next feasibility questionnaire arrives.

By Trialflow Team

Site selection decisions get made in rooms you are not in. A feasibility questionnaire, a CDA, maybe a 45-minute qualification call, and then a yes or no. Understanding what the people in that room are actually weighing changes how you present your site.

The decision is about risk, not capability

Sponsors and CROs are rarely asking "can this site run the study?" Most sites that get a feasibility questionnaire can. They are asking "what is the probability this site costs me a delay?" Every selection decision is a bet against the worst outcomes: a site that activates and enrolls nobody, a site that needs three months of extra startup, a site that generates a Form 483 observation attached to the sponsor's filing.

That reframing explains behavior that otherwise seems unfair. A mid-sized site with unremarkable enrollment but a clean monitoring history and fast contract turnaround often beats a site with a bigger patient population and a reputation for chaos.

What gets checked

Prior performance on comparable protocols. Not your total enrollment across all studies — performance in the same indication, with similar inclusion criteria, in a similar competitive landscape. Sponsors increasingly pull this from their own historical data and shared industry databases, so your self-reported numbers are being cross-checked.

Startup speed. Days from site selection to first patient in is one of the few metrics almost every sponsor tracks. Contract and budget negotiation length, IRB submission turnaround, and regulatory document completeness all feed it. A site that reliably activates in six weeks is worth a lot.

Data quality signals. Query rates, query resolution time, protocol deviation patterns, and timeliness of EDC entry. These show up in monitoring reports and travel between sponsors through CRO staff who move around.

Staff stability. High coordinator turnover reads as retraining risk and continuity risk. If your PI has changed twice in two years, expect questions.

Honesty on the questionnaire. Sponsors remember sites that promised 40 patients and enrolled 3 far more vividly than sites that promised 12 and delivered 14. Conservative, defensible projections build a reputation that compounds.

What you can do before the next questionnaire

  1. Keep a performance file per therapeutic area. Actual enrollment versus target, cycle times from selection to activation to FPI, screen failure rate, retention. Pull it from your own records, not memory.
  2. Measure your own startup cycle times. If you cannot say how long your contract review typically takes, you cannot argue that it is fast.
  3. Document your recruitment infrastructure concretely. "We have a database" means nothing. "We can query 1,400 consented contacts by diagnosis and medication history, and we typically reach 60 percent within five business days" means something.
  4. Fix your deviation patterns before someone else catalogs them. Repeated out-of-window visits or missed labs are usually a scheduling design problem, not a staff diligence problem.
  5. Name a single point of contact for startup. Sponsors notice when emails get answered in a day by someone who knows the file.

The relationship layer

Most sites underinvest in staying visible between studies. A short, specific annual update to CRA and sponsor contacts — new equipment, new sub-investigators, recent therapeutic-area experience — keeps you in consideration sets. Site selection often starts with a shortlist someone assembles from memory before any questionnaire goes out. Being on that list is the first thing worth competing for.

Enrolling studies shouldn't be this hard

Trialflow gives research sites one platform for lead management, AI trial matching, and recruitment analytics.

Request a Demo